Skip to menu Skip to content Skip to footer

2004

Conference Publication

Silibinin inhibits renal cell carcinoma cell growth via an insulin-like growth factor (IGFBP-3) independent pathway

Cheung, C. W., Vesey, D. A., Nicol, D. L. and Johnson, D. W. (2004). Silibinin inhibits renal cell carcinoma cell growth via an insulin-like growth factor (IGFBP-3) independent pathway. 40th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide Convention Centre, Adelaide, Australia, 1–3 September, 2004. Carlton, Vic. Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2004.00264.x

Silibinin inhibits renal cell carcinoma cell growth via an insulin-like growth factor (IGFBP-3) independent pathway

2004

Journal Article

The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease

Fathi, Robert, Isbel, Nicole, Short, Leanne, Haluska, Brian, Johnson, David and Marwick, Thomas H . (2004). The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease. American Journal of Kidney Diseases, 43 (1), 45-52. doi: 10.1053/j.ajkd.2003.09.012

The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease

2004

Conference Publication

Use of Cordyceps sinensis in the treatment of renal tubulointerstitial pathologies

Gobe, G. C., Hoy, W. E., Wojcikowski, K. and Johnson, D. W. (2004). Use of Cordyceps sinensis in the treatment of renal tubulointerstitial pathologies. Complementary and Alternative Therapies Symposium, Brisbane, Qld, Australia, 4-6 September, 2003.

Use of Cordyceps sinensis in the treatment of renal tubulointerstitial pathologies

2004

Journal Article

Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations

McDonald, Stephen P., Collins, John F., Rumpsfeld, Markus and Johnson, David W. (2004). Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Peritoneal Dialysis International, 24 (4), 340-346.

Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations

2003

Journal Article

Body mass index and renal transplant outcomes (Letters to the Editor)

Johnson, David W., Isbel, Nicole M., Brown, Allison M., Kay, Troy D., Franzen, Kirsten, Hawley, Carmel M., Campbell, Scott B., Wall, Darryl, Griffin, Anthony and Nicol, David L. (2003). Body mass index and renal transplant outcomes (Letters to the Editor). Transplantation, 76 (11), 1651-1651. doi: 10.1097/01.TP.0000084541.52199.6F

Body mass index and renal transplant outcomes (Letters to the Editor)

2003

Journal Article

Frequency and severity of acute rejection in live-versus cadaveric-donor renal transplants

Campbell, Scott B., Hothersall, Emma, Preston, John, Brown, Allison M., Hawley, Carmel M., Wall, Darryl, Griffin, Anthony D., Isbel, Nicole M., Nicol, David L. and Johnson, David W. (2003). Frequency and severity of acute rejection in live-versus cadaveric-donor renal transplants. Transplantation, 76 (10), 1452-1457. doi: 10.1097/01.TP.0000083895.64198.10

Frequency and severity of acute rejection in live-versus cadaveric-donor renal transplants

2003

Journal Article

Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations

Mcdonald, Stephen P., Collins, John F. and Johnson, David W. (2003). Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. Journal of The American Society of Nephrology, 14 (11), 2894-2901. doi: 10.1097/01.ASN.0000091587.55159.5F

Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations

2003

Journal Article

Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients

Johnson, David W., Nicol, David L., Preston, John M., Brown, Allison M., Hawley, Carmel M., Campbell, Scott B., Wall, Darryl, Griffin, Anthony D. and Isbel, Nicole M. (2003). Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients. Transplantation, 76 (3), 619-619. doi: 10.1097/01.TP.0000074314.46438.25

Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients

2003

Journal Article

Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations

Pat, Betty K., Cuttle, Leila, Watters, Dianne, Yang, Tao, Johnson, David W. and Gobe, Glenda C. (2003). Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations. Nephrology, 8 (4), 196-204. doi: 10.1046/j.1440-1797.2003.00162.x

Fibrogenic stresses activate different mitogen-activated protein kinase pathways in renal epithelial, endothelial or fibroblast cell populations

2003

Journal Article

A population-specific formula predicting creatinine excretion in continuous peritoneal dialysis (Letter to the Editor)

Rumpsfeld, M. and Johnson, D. W. (2003). A population-specific formula predicting creatinine excretion in continuous peritoneal dialysis (Letter to the Editor). Peritoneal Dialysis International, 23 (4), 406-408. doi: 10.1177/089686080302300419

A population-specific formula predicting creatinine excretion in continuous peritoneal dialysis (Letter to the Editor)

2003

Journal Article

Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice (Letters to the Editor)

Campbell, Scott B. and Johnson, David W. (2003). Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice (Letters to the Editor). Transplantation, 75 (11), 1917-1918. doi: 10.1097/01.TP.000065807.68596.16

Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice (Letters to the Editor)

2003

Journal Article

Correlates of subclinical left ventricular dysfunction in ESRD

Fathi, Robert, Isbel, Nicole, Haluska, Brian, Case, Colin, Johnson, David W. and Marwick, Thomas H. (2003). Correlates of subclinical left ventricular dysfunction in ESRD. American Journal of Kidney Diseases, 41 (5), 1016-1025. doi: 10.1016/S0272-6386(03)00199-9

Correlates of subclinical left ventricular dysfunction in ESRD

2003

Journal Article

Clinicians' attitudes to clinical practice guidelines

Johnson, David W. (2003). Clinicians' attitudes to clinical practice guidelines. Medical Journal of Australia, 178 (7), 354-355.

Clinicians' attitudes to clinical practice guidelines

2003

Journal Article

Recommendations for the use of icodextrin in peritoneal dialysis patients

Johnson, David W., Agar, John, Collins, John, Disney, Alex, Harris, David C. H., Ibels, Lloyd, Irish, Ashley, Saltissi, David and Suranyi, Michael (2003). Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology, 8 (1), 1-7. doi: 10.1046/j.1440-1797.2003.00117.x

Recommendations for the use of icodextrin in peritoneal dialysis patients

2003

Journal Article

A peritoneal dialysis patient with fatal culture-negative peritonitis

Johnson, David W., Gray, Nick and Snelling, Paul (2003). A peritoneal dialysis patient with fatal culture-negative peritonitis. Nephrology, 8 (1), 49-55. doi: 10.1046/j.1440-1797.2003.00119.x

A peritoneal dialysis patient with fatal culture-negative peritonitis

2003

Conference Publication

Activation of protease-activated receptors (PAR) on cultured human proximal tubular cells (PAR) mediates inflammatory and fibroproliferative responses

Vesey, D. A., Cheung, C. W., Gobe, G. C. and Johnson, D. W. (2003). Activation of protease-activated receptors (PAR) on cultured human proximal tubular cells (PAR) mediates inflammatory and fibroproliferative responses. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, W. A., 31 August- 3 September, 2003. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1797.8.s3.1.x

Activation of protease-activated receptors (PAR) on cultured human proximal tubular cells (PAR) mediates inflammatory and fibroproliferative responses

2003

Conference Publication

Microarray gene expression analysis reveals role for JAK signaling pathway in oxidative stress-induced renal fibrosis

Pat, B. K., Tang, T., Watters, D., Johnson, D. W. and Gobe, G. C. (2003). Microarray gene expression analysis reveals role for JAK signaling pathway in oxidative stress-induced renal fibrosis. 39th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, Western Australia, 1-3 September, 2003.

Microarray gene expression analysis reveals role for JAK signaling pathway in oxidative stress-induced renal fibrosis

2003

Conference Publication

Medicinal herbal extracts - treatment of renal disease

Gobe, G. C., Hoy, W. E., Wojcikowski, K., Myers, S. P. and Johnson, D. W. (2003). Medicinal herbal extracts - treatment of renal disease. Complementary and Alternative Therapies Symposium, Brisbane, Qld, Australia, 4-6 September, 2003.

Medicinal herbal extracts - treatment of renal disease

2003

Conference Publication

Activation of ERK in renal fibrosis after UUO stimulates epithelial proliferation and not fibroblast apoptosis

Pat, B. K., Yang, T., Watters, D., Johnson, D. and Gobe, G. C. (2003). Activation of ERK in renal fibrosis after UUO stimulates epithelial proliferation and not fibroblast apoptosis. 39th Annual Scientific Meeting ANZ Society of Nephrology, Perth, 31 Aug - 3 Sep, 2003. Carlton South, Australia: Blackwell Publishing Asia.

Activation of ERK in renal fibrosis after UUO stimulates epithelial proliferation and not fibroblast apoptosis

2003

Journal Article

Cost Savings from Peritoneal Dialysis Therapy Time Extension Using Icodextrin

Johnson, David W., Vincent, Kaia, Blizzard, Sophie, Rumpsfeld, Markus and Just, Paul (2003). Cost Savings from Peritoneal Dialysis Therapy Time Extension Using Icodextrin. Advances in Peritoneal Dialysis, 19, 81-85.

Cost Savings from Peritoneal Dialysis Therapy Time Extension Using Icodextrin